
  
    
      
        Introduction_NNP
        Embryonic_NNP stem_VB (_( ES_NNP )_) cells_NNS are_VBP pluripotent_NN cells_NNS derived_VBN from_IN the_DT inner_JJ cell_NN mass_NN of_IN the_DT
        blastocyst_NN that_WDT can_MD be_VB maintained_VBN in_IN culture_NN for_IN an_DT extended_VBN period_NN of_IN time_NN without_IN losing_VBG
        differentiation_NN potential_JJ ._. The_DT successful_JJ isolation_NN of_IN human_JJ ES_NNP cells_NNS (_( hESCs_NNS )_) has_VBZ raised_VBN
        the_DT hope_NN that_IN these_DT cells_NNS may_MD provide_VB a_DT universal_JJ tissue_NN source_NN to_TO treat_VB many_JJ human_JJ
        diseases_NNS ._. However_RB ,_, directed_VBN differentiation_NN of_IN hESCs_NNS into_IN specific_JJ tissue_NN types_NNS poses_VBZ a_DT
        formidable_JJ challenge_NN ._. Protocols_NNP are_VBP currently_RB available_JJ for_IN only_RB a_DT few_JJ cell_NN types_NNS ,_, mostly_RB
        of_IN neural_NN identity_NN [_NN 1_CD –_NN 3_CD ]_NN ,_, and_CC differentiation_NN into_IN many_JJ of_IN the_DT cell_NN types_NNS derived_VBN from_IN the_DT
        paraxial_NN mesoderm_NN has_VBZ not_RB been_VBN reported_VBN ,_, with_IN the_DT exception_NN of_IN a_DT recent_JJ study_NN indicating_VBG
        osteoblastic_JJ differentiation_NN [_NN 4_CD ]_NN ._. Mesenchymal_NNP stem_VB cells_NNS (_( MSCs_NNP )_) have_VBP been_VBN isolated_VBN from_IN the_DT
        adult_NN bone_NN marrow_NN [_NN 5_CD ]_NN ,_, adipose_NN tissue_NN [_NN 6_CD ]_NN ,_, and_CC dermis_NNS and_CC other_JJ connective_JJ tissues_NNS [_NN 7_CD ]_NN ._.
        Harvesting_NNP MSCs_NNP from_IN any_DT of_IN these_DT sources_NNS requires_VBZ invasive_JJ procedures_NNS and_CC the_DT availability_NN
        of_IN a_DT suitable_JJ donor_NN ._. The_DT number_NN of_IN MSCs_NNP that_WDT can_MD be_VB obtained_VBN from_IN a_DT single_JJ donor_NN is_VBZ
        limited_VBN ,_, and_CC the_DT capacity_NN of_IN these_DT cells_NNS for_IN long-term_JJ proliferation_NN is_VBZ rather_RB poor_JJ ._. In_IN
        contrast_NN ,_, hESCs_NNS could_MD provide_VB an_DT unlimited_JJ number_NN of_IN specialized_JJ cells_NNS ._. In_IN this_DT study_NN ,_, we_PRP
        present_JJ techniques_NNS for_IN the_DT generation_NN and_CC purification_NN of_IN mesenchymal_NN precursors_NNS from_IN hESCs_NNS
        and_CC their_PRP$ directed_VBN differentiation_NN in_IN vitro_NN into_IN various_JJ mesenchymal_NN derivatives_NNS ,_, including_VBG
        skeletal_NN myoblasts_NNS ._. Our_PRP$ isolation_NN method_NN for_IN mesenchymal_NN precursors_NNS is_VBZ the_DT first_JJ example_NN ,_,
        to_TO our_PRP$ knowledge_NN ,_, of_IN efficiently_RB deriving_VBG structures_NNS of_IN the_DT paraxial_NN mesoderm_NN from_IN ES_NNP
        cells_NNS ,_, and_CC further_JJ highlights_VBZ the_DT potential_NN of_IN hESCs_NNS for_IN basic_JJ biology_NN and_CC regenerative_JJ
        medicine_NN ._.
      
      
        Methods_NNP
        
          Cell_NNP Culture_NNP and_CC FACS_NNP
          Undifferentiated_NNP hESCs_NNS ,_, H_NNP 1_CD (_( WA-_NNP 01_CD ,_, XY_NNP ,_, passages_NNS 40_CD –_NN 65_CD )_) and_CC H_NNP 9_CD (_( WA-_NNP 09_CD ,_, XX_NNP ,_, passages_NNS
          35_CD –_NN 45_CD )_) ,_, were_VBD cultured_JJ on_IN mitotically_RB inactivated_JJ mouse_NN embryonic_JJ fibroblasts_NNS (_( Specialty_NNP
          Media_NNP ,_, Phillipsburg_NNP ,_, New_NNP Jersey_NNP ,_, United_NNP States_NNPS )_) and_CC maintained_VBN under_IN growth_NN conditions_NNS
          and_CC passaging_VBG techniques_NNS described_VBD previously_RB [_NN 3_CD ]_NN ._. OP_NNP 9_CD cells_NNS were_VBD maintained_VBN in_IN alpha_NN MEM_NNP
          medium_NN containing_VBG 20_CD %_NN fetal_JJ bovine_JJ serum_NN (_( FBS_NNP )_) and_CC 2_CD mM_NN L-_NNP glutamine_NN ._. Mesenchymal_NNP
          differentiation_NN was_VBD induced_VBN by_IN plating_VBG 10_CD ×_NN 10_CD
          3_CD to_TO 25_CD ×_NN 10_CD
          3_CD cells_NNS /_NN cm_NN
          2_CD on_IN a_DT monolayer_NN of_IN OP_NNP 9_CD cells_NNS in_IN the_DT presence_NN of_IN 20_CD %_NN heat-inactivated_JJ
          FBS_NNP in_IN alpha_NN MEM_NNP medium_NN ._. Flow-activated_NNP cell_NN sorting_VBG (_( FACS_NNP )_) (_( CD_NNP 73_CD -_: PE_NNP ;_: PharMingen_NNP ,_, San_NNP
          Diego_NNP ,_, California_NNP ,_, United_NNP States_NNPS )_) was_VBD performed_VBN on_IN a_DT MoFlo_NNP (_( Cytomation_NNP ,_, Fort_NNP Collins_NNP ,_,
          Colorado_NNP ,_, United_NNP States_NNPS )_) ._. All_DT human_JJ ES_NNP cell–derived_JJ mesenchymal_NN precursor_NN cell_NN (_( hESMPC_NN )_)
          lines_NNS in_IN this_DT study_NN are_VBP of_IN polyclonal_NN origin_NN ._. Primary_JJ human_JJ bone_NN marrow–derived_JJ MSCs_NNP and_CC
          primary_JJ human_JJ foreskin_NN fibroblasts_NNS (_( both_DT from_IN Poietics_NNP ,_, Cambrex_NNP ,_, East_NNP Rutherford_NNP ,_, New_NNP
          Jersey_NNP ,_, United_NNP States_NNPS )_) were_VBD grown_VBN in_IN alpha_NN MEM_NNP medium_NN containing_VBG 10_CD %_NN FBS_NNP and_CC 2_CD mM_NN
          L-_NNP glutamine_NN ._.
        
        
          Adipocytic_NNP Differentiation_NNP
          hESMPCs_NNS are_VBP grown_VBN to_TO confluence_NN followed_VBN by_IN exposure_NN to_TO 1_CD mM_NN dexamethasone_NN ,_, 10_CD μg_NN /_NN ml_NN
          insulin_NN ,_, and_CC 0_CD ._. 5_CD mM_NN isobutylxanthine_NN (_( all_DT from_IN Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, Missouri_NNP ,_, United_NNP States_NNPS )_)
          in_IN alpha_NN MEM_NNP medium_NN containing_VBG 10_CD %_NN FBS_NNP for_IN 2_CD –_NN 4_CD wk_NN ._. Data_NNP were_VBD confirmed_VBN in_IN hESMPC-H_JJ 1_CD ._. 1_LS ,_,
          -_: H_NNP 1_CD ._. 2_LS ,_, -_: H_NNP 1_CD ._. 3_LS ,_, and_CC -_: H_NNP 9_CD ._. 1_LS (_( hESMPC-H_JJ 1_CD ._. 4_LS was_VBD not_RB tested_VBN )_) ._.
        
        
          Chondrocytic_NNP Differentiation_NNP
          Differentiation_NNP of_IN hESMPCs_NNS was_VBD induced_VBN in_IN pellet_NN culture_NN [_NN 5_CD ]_NN by_IN exposure_NN to_TO 10_CD ng_NN /_NN ml_NN
          TGF-β_NNP 3_CD (_( R_NN &_CC D_NNP Systems_NNPS ,_, Minneapolis_NNP ,_, Minnesota_NNP ,_, United_NNP States_NNPS )_) and_CC 200_CD μM_NN ascorbic_JJ
          acid_NN (_( Sigma_NNP )_) in_IN alpha_NN MEM_NNP medium_NN containing_VBG 10_CD %_NN FBS_NNP for_IN 3_CD –_NN 4_CD wk_NN ._. Data_NNP were_VBD confirmed_VBN in_IN
          hESMPC-H_JJ 1_CD ._. 1_LS ,_, -_: H_NNP 1_CD ._. 3_LS ,_, and_CC -_: H_NNP 9_CD ._. 1_LS (_( hESMPC-H_JJ 1_CD ._. 2_LS and_CC -_: H_NNP 1_CD ._. 4_LS were_VBD not_RB tested_VBN )_) ._.
        
        
          Osteogenic_NNP Differentiation_NNP
          hESMPCs_NNS were_VBD plated_JJ at_IN low_JJ density_NN (_( 1_CD ×_NN 10_CD
          3_CD to_TO 2_CD ._. 5_CD ×_NN 10_CD
          3_CD cells_NNS /_NN cm_NN
          2_LS )_) on_IN tissue-culture-treated_JJ dishes_NNS in_IN the_DT presence_NN of_IN 10_CD mM_NN
          β-glycerol_JJ phosphate_NN (_( Sigma_NNP )_) ,_, 0_CD ._. 1_CD μM_NN dexamethasone_NN ,_, and_CC 200_CD μM_NN ascorbic_JJ acid_NN in_IN alpha_NN MEM_NNP
          medium_NN containing_VBG 10_CD %_NN FBS_NNP for_IN 3_CD –_NN 4_CD wk_NN ._. Data_NNP were_VBD confirmed_VBN in_IN hESMPC-H_JJ 1_CD ._. 1_LS ,_, -_: H_NNP 1_CD ._. 3_LS ,_, and_CC
          -_: H_NNP 9_CD ._. 1_LS (_( hESMPC-H_JJ 1_CD ._. 2_LS and_CC -_: H_NNP 1_CD ._. 4_LS were_VBD not_RB tested_VBN )_) ._.
        
        
          Myogenic_NNP Differentiation_NNP
          Confluent_NNP hESMPCs_NNS were_VBD maintained_VBN for_IN 2_CD –_NN 3_CD wk_NN in_IN alpha_NN MEM_NNP medium_NN with_IN 20_CD %_NN
          heat-inactivated_JJ FBS_NNP ._. More_RBR rapid_JJ induction_NN was_VBD observed_VBN in_IN the_DT presence_NN of_IN medium_NN
          conditioned_VBN for_IN 24_CD h_NN by_IN differentiated_JJ C_NNP 2_CD C_NNP 12_CD cells_NNS ._. Coculture_NNP of_IN hESMPCs_NNS and_CC C_NNP 2_CD C_NNP 12_CD cells_NNS
          was_VBD carried_VBN out_IN in_IN alpha_NN MEM_NNP with_IN 3_CD %_NN horse_NN serum_NN and_CC 1_CD %_NN FBS_NNP [_NN 8_CD ]_NN ._. Data_NNP were_VBD confirmed_VBN in_IN
          hESMPC-H_JJ 1_CD ._. 3_LS ,_, -_: H_NNP 1_CD ._. 4_LS ,_, and_CC -_: H_NNP 9_CD ._. 1_LS (_( hESMPC-H_JJ 1_CD ._. 1_LS and_CC -_: H_NNP 1_CD ._. 2_LS were_VBD not_RB tested_VBN )_) ._.
        
        
          Cytochemistry_NNP
          Immunocytochemistry_NNP for_IN all_DT surface_NN markers_NNS was_VBD performed_VBN on_IN live_VB cells_NNS ._. Monoclonal_NNP
          antibodies_NNS VCAM_NNP ,_, STRO-_NNP 1_CD ,_, ICAM-_NNP 1_CD (_( CD_NNP 54_CD )_) ,_, CD_NNP 105_CD ,_, CD_NNP 29_CD ,_, and_CC MF_NNP 20_CD were_VBD from_IN Developmental_NNP
          Studies_NNPS Hybridoma_NNP Bank_NNP (_( University_NNP of_IN Iowa_NNP ,_, Iowa_NNP City_NNP ,_, Iowa_NNP ,_, United_NNP States_NNPS )_) ;_: CD_NNP 73_CD ,_, CD_NNP 44_CD ,_,
          and_CC ALCAM_NNP (_( CD_NNP 166_CD )_) were_VBD from_IN BD_NNP Biosciences_NNP Pharmingen_NNP (_( San_NNP Diego_NNP ,_, California_NNP ,_, United_NNP
          States_NNPS )_) ._. All_DT other_JJ immunocytochemical_JJ analyses_NNS were_VBD performed_VBN after_IN fixation_NN in_IN 4_CD %_NN
          paraformaldehyde_NN and_CC 0_CD ._. 15_CD %_NN picric_JJ acid_NN ,_, followed_VBN by_IN permeabilization_NN in_IN 0_CD ._. 3_CD %_NN Triton_NNP X_NNP 100_CD ._.
          Polyclonal_NNP antibodies_NNS used_VBN were_VBD MyoD_NNP (_( Santa_NNP Cruz_NNP Biotechnology_NNP ,_, Santa_NNP Cruz_NNP ,_, California_NNP ,_,
          United_NNP States_NNPS )_) and_CC nestin_NN (_( gift_NN from_IN R_NN ._. McKay_NNP )_) ;_: monoclonal_NN antibodies_NNS were_VBD vimentin_NN ,_,
          alpha_NN smooth_JJ muscle_NN actin_NN ,_, fast-switch_JJ myosin_NN ,_, pan-cytokeratin_JJ (_( all_DT from_IN Sigma_NNP )_) ,_, and_CC
          human_JJ nuclear_JJ antigen_NN (_( Chemicon_NNP ,_, Temecula_NNP ,_, California_NNP ,_, United_NNP States_NNPS )_) ._.
          Alkaline_NNP phosphatase_NN reaction_NN was_VBD performed_VBN using_VBG a_DT commercially_RB available_JJ kit_NN
          (_( Kit-_NNP 86_CD ;_: Sigma_NNP )_) and_CC the_DT mineral_NN was_VBD stained_JJ with_IN silver_NN nitrate_NN according_VBG to_TO the_DT von_NNP
          Kossa_NNP method_NN ._. Fat_NNP granules_NNS were_VBD visualized_JJ by_IN Oil_NNP Red_NNP O_NNP staining_VBG solution_NN (_( Sigma_NNP )_) ._. Alcian_NNP
          Blue_NNP (_( Sigma_NNP )_) was_VBD used_VBN to_TO detect_VB extracellular_NN matrix_NN proteoglycans_NNS in_IN chondrogenic_JJ
          cultures_NNS ._.
        
        
          Gene-_NNP Expression_NNP Analyses_NNS
          
            RT-PCR_NNP analysis_NN
            Total_NNP RNA_NNP was_VBD extracted_VBN by_IN using_VBG the_DT RNeasy_NNP kit_NN and_CC DNase_NNP I_PRP treatment_NN (_( Qiagen_NNP ,_,
            Valencia_NNP ,_, California_NNP ,_, United_NNP States_NNPS )_) ._. Total_NNP RNA_NNP (_( 2_CD μg_NN each_DT )_) was_VBD reverse_VB transcribed_JJ
            (_( SuperScript_NNP ;_: Invitrogen_NNP ,_, Carlsbad_NNP ,_, California_NNP ,_, United_NNP States_NNPS )_) ._. PCR_NNP conditions_NNS were_VBD
            optimized_JJ and_CC linear_JJ amplification_NN range_NN was_VBD determined_VBN for_IN each_DT primer_NN by_IN varying_VBG
            annealing_VBG temperature_NN and_CC cycle_NN number_NN ._. PCR_NNP products_NNS were_VBD identified_VBN by_IN size_NN ,_, and_CC
            identity_NN was_VBD confirmed_VBN by_IN DNA_NNP sequencing_VBG ._. Primer_NNP sequences_NNS ,_, cycle_NN numbers_NNS ,_, and_CC
            annealing_VBG temperatures_NNS are_VBP provided_VBN in_IN Table_NNP S_NNP 1_CD ._.
          
          
            Affymetrix_NNP analysis_NN
            Total_NNP RNA_NNP (_( 5_CD μg_NN )_) from_IN primary_JJ MSCs_NNP ,_, from_IN hESMPC-H_JJ 9_CD ._. 1_LS ,_, hESMPC-H_JJ 1_CD ._. 2_LS ,_, and_CC three_CD samples_NNS
            of_IN undifferentiated_JJ hESCs_NNS (_( H_NNP 1_CD ;_: passages_NNS 42_CD –_NN 46_CD )_) ,_, were_VBD processed_VBN by_IN the_DT Memorial_NNP
            Sloan-_NNP Kettering_NNP Cancer_NNP Center_NNP Genomics_NNP Core_NNP Facility_NNP and_CC hybridized_JJ on_IN Affymetrix_NNP
            (_( Santa_NNP Clara_NNP ,_, California_NNP ,_, United_NNP States_NNPS )_) U_NNP 133_CD A_DT human_JJ oligonucleotide_NN arrays_NNS ._. Data_NNP were_VBD
            analyzed_VBN using_VBG MAS_NNP 5_CD ._. 0_CD (_( Affymetrix_NNP )_) software_NN ._. Transcripts_NNP selectively_RB expressed_VBD in_IN each_DT
            of_IN the_DT mesenchymal_NN cell_NN populations_NNS (_( MSC_NNP ,_, hESMPC-H_JJ 9_CD ._. 1_LS ,_, and_CC hESMPC-H_JJ 1_CD ._. 2_LS )_) were_VBD defined_VBN as_IN
            those_DT called_VBN “ increased_VBN” by_IN the_DT MAS_NNP 5_CD ._. 0_CD algorithm_NN in_IN each_DT of_IN three_CD comparisons_NNS with_IN
            independent_JJ samples_NNS of_IN undifferentiated_JJ hESCs_NNS ._. A_DT Venn_NNP diagram_NN was_VBD generated_VBN to_TO
            visualize_VB overlap_VB in_IN gene_NN expression_NN ._. Further_RB statistical_JJ analyses_NNS were_VBD performed_VBN as_IN
            described_VBN below_IN ._.
          
        
      
      
        Results_NNS
        Mesenchymal_NNP differentiation_NN of_IN hESCs_NNS (_( lines_NNS H_NNP 1_CD [_NN WA-_NNP 01_CD ]_NN and_CC H_NNP 9_CD [_NN WA-_NNP 09_CD ]_NN )_) [_NN 9_CD ]_NN was_VBD induced_VBN
        by_IN plating_VBG undifferentiated_JJ hESCs_NNS on_IN a_DT monolayer_NN of_IN murine_NN OP_NNP 9_CD stromal_NN cells_NNS [_NN 10_CD ]_NN ,_, in_IN the_DT
        presence_NN of_IN 20_CD %_NN heat-inactivated_JJ FBS_NNP in_IN alpha_NN MEM_NNP medium_NN ._. OP_NNP 9_CD cells_NNS have_VBP been_VBN previously_RB
        shown_VBN to_TO induce_VB blood_NN cell_NN differentiation_NN from_IN mouse_NN ES_NNP cells_NNS [_NN 11_CD ]_NN ._. After_IN 40_CD d_SYM of_IN
        coculture_NN ,_, cells_NNS were_VBD harvested_VBN and_CC sorted_VBN by_IN FACS_NNP for_IN CD_NNP 73_CD ,_, a_DT surface_NN marker_NN expressed_VBD in_IN
        adult_NN MSCs_NNP [_NN 5_CD ]_NN (_( Figure_NN 1_CD A_DT )_) ._. An_DT average_NN of_IN 5_CD %_NN CD_NNP 73_CD +_NN cells_NNS was_VBD obtained_VBN from_IN the_DT mixed_JJ
        culture_NN of_IN OP_NNP 9_CD and_CC differentiated_JJ hESC_NN progeny_NN ._. CD_NNP 73_CD +_NN cells_NNS were_VBD replated_JJ in_IN the_DT absence_NN of_IN
        stromal_NN feeders_NNS on_IN tissue_NN culture_NN plates_NNS and_CC expanded_VBN in_IN alpha_NN MEM_NNP medium_NN with_IN 20_CD %_NN FBS_NNP for_IN
        7_CD –_NN 14_CD d_SYM ._. We_PRP next_RB established_VBD the_DT membrane_NN antigen_NN profile_NN of_IN the_DT resulting_VBG population_NN of_IN
        flat_JJ spindle-like_JJ cells_NNS ._. The_DT H_NNP 1_CD -_: and_CC H_NNP 9_CD -_: derived_VBN CD_NNP 73_CD +_NN cells_NNS expressed_VBD a_DT comprehensive_JJ set_NN
        of_IN markers_NNS that_WDT are_VBP considered_VBN to_TO define_VB adult_NN MSCs_NNP ,_, including_VBG CD_NNP 105_CD (_( SH_NNP 2_LS )_) ,_, STRO-_NNP 1_CD ,_, VCAM_NNP
        (_( CD_NNP 106_CD )_) ,_, CD_NNP 29_CD (_( integrin_NN β_NN 1_LS )_) ,_, CD_NNP 44_CD ,_, ICAM_NNP -_: 1_CD (_( CD_NNP 54_CD )_) ,_, ALCAM_NNP (_( CD_NNP 166_CD )_) ,_, vimentin_NN ,_, and_CC alpha_NN smooth_JJ
        muscle_NN actin_NN (_( Figure_NN 1_CD B_NNP and_CC 1_CD C_NNP )_) ._. The_DT cells_NNS were_VBD negative_JJ for_IN hematopoietic_JJ markers_NNS such_JJ as_IN
        CD_NNP 34_CD ,_, CD_NNP 45_CD ,_, and_CC CD_NNP 14_CD ._. They_PRP were_VBD also_RB negative_JJ for_IN neuroectodermal_NN ,_, epithelial_NN ,_, and_CC muscle_NN
        cell_NN markers_NNS including_VBG nestin_NN ,_, pancytokeratin_NN ,_, and_CC desmin_NN (_( data_NNS not_RB shown_VBN )_) ._. The_DT human_JJ
        identity_NN of_IN these_DT presumed_VBN mesenchymal_NN cells_NNS (_( termed_VBD hESMPC-H_JJ 1_CD ._. 1_LS ,_, -_: H_NNP 1_CD ._. 2_LS ,_, -_: H_NNP 1_CD ._. 3_LS ,_, -_: H_NNP 1_CD ._. 4_LS ,_, and_CC
        -_: H_NNP 9_CD ._. 1_LS )_) was_VBD confirmed_VBN for_IN all_DT experiments_NNS by_IN immunocytochemistry_NN for_IN human_JJ nuclear_JJ antigen_NN
        to_TO rule_VB out_RP the_DT possibility_NN of_IN contamination_NN with_IN OP_NNP 9_CD cells_NNS (_( Figure_NNP S_NNP 1_LS )_) ._.
        To_TO further_VB characterize_VB hESMPCs_NNS ,_, we_PRP performed_VBD genome-wide_JJ expression_NN analysis_NN using_VBG
        oligonucleotide_NN arrays_NNS (_( Affymetrix_NNP U_NNP 133_CD A_DT )_) ._. The_DT expression_NN profiles_NNS of_IN hESMPC-H_JJ 1_CD ._. 2_LS and_CC
        hESMPC-H_JJ 9_CD ._. 1_LS were_VBD compared_VBN with_IN that_DT of_IN human_JJ primary_JJ adult_NN MSCs_NNP ._. Housekeeping_NNP genes_NNS for_IN
        each_DT of_IN the_DT mesenchymal_NN cell_NN populations_NNS were_VBD eliminated_VBN by_IN subtracting_VBG those_DT transcripts_NNS
        also_RB expressed_VBD in_IN at_IN least_JJS one_CD of_IN three_CD independent_JJ samples_NNS of_IN undifferentiated_JJ hESCs_NNS ._.
        Based_VBN on_IN this_DT analysis_NN ,_, 1_CD ,_, 280_CD transcripts_NNS were_VBD selectively_RB expressed_VBN in_IN hESMPC-H_JJ 1_CD ._. 2_LS ,_, 932_CD
        transcripts_NNS in_IN hESMPC-H_JJ 9_CD ._. 1_LS ,_, and_CC 1_CD ,_, 218_CD transcripts_NNS in_IN primary_JJ adult_NN MSCs_NNP ._. A_DT remarkable_JJ
        overlap_VB of_IN 579_CD transcripts_NNS shared_VBN among_IN the_DT three_CD mesenchymal_NN populations_NNS was_VBD observed_VBN
        (_( Figure_NN 1_CD D_NNP )_) ._. Using_VBG the_DT genes_NNS that_WDT were_VBD selected_VBN in_IN the_DT initial_JJ filter_NN ,_, we_PRP performed_VBD a_DT
        statistical_JJ analysis_NN on_IN the_DT expression_NN levels_NNS to_TO determine_VB whether_IN the_DT genes_NNS were_VBD expressed_VBN
        significantly_RB differently_RB in_IN the_DT two_CD cell_NN types_NNS ._. We_PRP used_VBD a_DT Bayesian_NNP extension_NN to_TO the_DT
        standard_JJ 
        t_NN -_: test_NN [_NN 12_CD ]_NN to_TO assess_VB this_DT difference_NN ._. Of_IN the_DT 579_CD genes_NNS ,_, 412_CD of_IN them_PRP
        were_VBD significantly_RB different_JJ ,_, at_IN a_DT false_JJ discovery_NN rate_NN cutoff_NN of_IN 0_CD ._. 05_CD ._. The_DT relative_JJ fold_VB
        changes_NNS were_VBD also_RB extremely_RB large_JJ in_IN many_JJ of_IN the_DT cases_NNS ._. We_PRP also_RB looked_VBD at_IN the_DT variance_NN of_IN
        the_DT expression_NN levels_NNS within_IN the_DT cell_NN types_NNS ._. For_IN the_DT MSCs_NNP ,_, 94_CD %_NN had_VBD a_DT coefficient_NN of_IN
        variation_NN less_JJR than_IN 20_CD %_NN for_IN the_DT expression_NN (_( log_VB transformed_VBN )_) ;_: for_IN the_DT ES-derived_NNP cells_NNS ,_, 72_CD %_NN
        had_VBD a_DT coefficient_NN of_IN variation_NN less_JJR than_IN 20_CD %_NN ._. Numerous_JJ known_VBN MSC_NNP markers_NNS were_VBD included_VBN in_IN
        the_DT list_NN of_IN 412_CD genes_NNS ,_, such_JJ as_IN the_DT 
        mesenchymal_NN stem_NN cell_NN protein_NN DSC_NNP 54_CD (_( 13_CD ._. 9_CD -_: fold_VB increase_NN ,_, 
        p_NN <_NN 0_CD ._. 001_CD )_) ,_, 
        neuropilin_NN 1_CD (_( 30_CD ._. 4_LS -_: fold_VB increase_NN ,_, 
        p_NN <_NN 0_CD ._. 001_CD )_) ,_, 
        hepatocyte_NN growth_NN factor_NN (_( 48_CD ._. 1_LS -_: fold_VB increase_NN ,_, 
        p_NN <_NN 0_CD ._. 001_CD )_) ,_, 
        forkhead_NN box_NN D_NNP 1_CD (_( 14_CD ._. 8_CD -_: fold_VB increase_NN ,_, 
        p_NN <_NN 0_CD ._. 001_CD )_) ,_, and_CC 
        notch_NN homolog_NN 2_CD (_( 2_CD ._. 9_CD -_: fold_VB increase_NN ,_, 
        p_NN <_NN 0_CD ._. 001_CD )_) ._. Table_NNP S_NNP 2_CD lists_NNS the_DT 
        p_NN -_: values_NNS from_IN the_DT test_NN ,_, the_DT mean_NN and_CC standard_JJ deviation_NN of_IN the_DT
        expression_NN levels_NNS ,_, and_CC the_DT relative_JJ fold_VB change_NN of_IN all_DT 412_CD genes_NNS between_IN the_DT two_CD types_NNS ._.
        Known_VBN markers_NNS of_IN MSCs_NNP ,_, such_JJ as_IN mesenchymal_NN stem_NN cell_NN protein_NN DSC_NNP 54_CD ,_, were_VBD all_DT included_VBD
        within_IN the_DT 579_CD shared_VBN transcripts_NNS ._. These_DT findings_NNS support_VBP the_DT immunocytochemical_JJ data_NN and_CC
        suggest_VBP that_IN hESMPCs_NNS and_CC primary_JJ MSCs_NNP are_VBP highly_RB related_VBN ._.
        MSCs_NNP are_VBP characterized_VBN functionally_RB by_IN their_PRP$ ability_NN to_TO differentiate_VB into_IN mesenchymal_NN
        tissues_NNS ,_, such_JJ as_IN fat_JJ ,_, cartilage_NN ,_, and_CC bone_NN ._. Therefore_RB ,_, we_PRP tested_VBD whether_IN hESMPCs_NNS have_VBP the_DT
        same_JJ potential_JJ (_( Figure_NN 2_LS )_) ._.
        Adipocytic_NNP differentiation_NN of_IN hESMPCs_NNS was_VBD induced_VBN under_IN conditions_NNS described_VBD previously_RB
        for_IN primary_JJ adult_NN MSCs_NNP [_NN 5_CD ]_NN ._. Appearance_NNP of_IN cells_NNS harboring_VBG fat_JJ granules_NNS was_VBD observed_VBN after_IN
        10_CD –_NN 14_CD d_SYM in_IN culture_NN ._. After_IN 3_CD wk_NN of_IN induction_NN ,_, more_JJR than_IN 70_CD %_NN of_IN the_DT cells_NNS displayed_VBD Oil_NNP Red_NNP
        O_NNP +_NN fat_JJ granules_NNS ,_, and_CC 
        PPARγ_NNP ,_, a_DT marker_NN of_IN adipocytic_JJ differentiation_NN ,_, was_VBD detected_VBN by_IN RT-PCR_NNP ._.
        (_( Figure_NN 2_CD A_DT )_) ._.
        Chondrocytic_NNP differentiation_NN was_VBD achieved_VBN using_VBG the_DT pellet_NN culture_NN system_NN [_NN 5_CD ]_NN ._. After_IN 28_CD
        d_SYM in_IN culture_NN ,_, more_JJR than_IN 50_CD %_NN of_IN all_DT cells_NNS exhibited_VBN robust_JJ staining_VBG for_IN Alcian_NNP Blue_NNP ,_, a_DT
        marker_NN specific_JJ for_IN extracellular_NN matrix_NN proteoglycans_NNS ._. Chondrocytic_NNP differentiation_NN was_VBD
        confirmed_VBN by_IN the_DT gene_NN expression_NN of_IN 
        collagen_NN II_NNP and_CC 
        aggrecan_NN ,_, two_CD components_NNS of_IN extracellular_NN matrix_NN selectively_RB expressed_VBN
        by_IN chondrocytes_NNS ,_, using_VBG RT-PCR_NNP (_( Figure_NN 2_CD B_NNP )_) ._.
        Osteogenic_NNP differentiation_NN was_VBD induced_VBN in_IN the_DT presence_NN of_IN β-glycerolphosphate_JJ [_NN 5_CD ]_NN ._.
        Osteogenesis_NNP was_VBD demonstrated_VBN by_IN specific_JJ staining_VBG for_IN calcium_NN deposition_NN in_IN the_DT matrix_NN
        (_( von_NNP Kossa_NNP ,_, Figure_NN 2_CD C_NNP ;_: or_CC Alizarin_NNP Red_NNP ,_, Figure_NNP S_NNP 2_CD A_DT )_) and_CC increased_VBN expression_NN of_IN 
        bone-specific_JJ alkaline_NN phosphatase_NN and_CC 
        bone_NN sialoprotein_NN at_IN day_NN 28_CD of_IN treatment_NN (_( Figures_NNS 2_CD C_NNP and_CC S_NNP 2_CD B_NNP )_) ._. At_IN day_NN 28_CD ,_,
        Alizarin_NNP Red_NNP staining_VBG was_VBD detected_VBN in_IN approximately_RB 70_CD %_NN of_IN all_DT cells_NNS ._. Throughout_IN these_DT
        studies_NNS ,_, human_JJ adult_NN MSCs_NNP and_CC foreskin_NN fibroblasts_NNS were_VBD used_VBN as_IN positive_JJ and_CC negative_JJ
        controls_NNS ,_, respectively_RB ._.
        In_IN addition_NN to_TO adipocytic_JJ ,_, chondrocytic_JJ ,_, and_CC osteogenic_JJ differentiation_NN ,_, reports_NNS
        suggested_VBD that_DT adult_NN MSCs_NNP can_MD form_VB skeletal_NN muscle_NN [_NN 13_CD ]_NN ._. Although_IN generation_NN of_IN skeletal_NN
        muscle_NN cells_NNS from_IN adult_NN MSCs_NNP remains_VBZ controversial_JJ ,_, we_PRP tested_VBD whether_IN hESMPCs_NNS exhibit_NN this_DT
        potential_NN ._. Under_IN the_DT conditions_NNS previously_RB described_VBD [_NN 13_CD ]_NN ,_, hESMPC-H_JJ 1_CD ._. 1_LS and_CC -_: H_NNP 9_CD ._. 1_LS did_VBD not_RB
        yield_VB significant_JJ numbers_NNS of_IN MyoD_NNP +_NN cells_NNS after_IN 15_CD –_NN 20_CD d_SYM in_IN culture_NN ._. However_RB ,_, when_WRB confluent_NN
        cells_NNS were_VBD maintained_VBN in_IN culture_NN in_IN the_DT presence_NN or_CC absence_NN of_IN 5_CD -_: AzaC_NNP without_IN passage_NN for_IN
        more_JJR than_IN 21_CD d_SYM ,_, expression_NN of_IN specific_JJ skeletal_NN muscle_NN markers_NNS such_JJ as_IN MyoD_NNP and_CC fast-switch_JJ
        myosin_NN was_VBD observed_VBN (_( Figure_NN 3_CD A_DT )_) ._. More_RBR rapid_JJ myogenic_JJ differentiation_NN was_VBD obtained_VBN in_IN the_DT
        presence_NN of_IN 24_CD -_: h-conditioned_JJ medium_NN from_IN the_DT murine_NN myoblastic_JJ cell_NN line_NN C_NNP 2_CD C_NNP 12_CD previously_RB
        induced_VBN to_TO form_VB myotubes_NNS [_NN 14_CD ]_NN ._. Direct_JJ coculture_NN of_IN hESMPCs_NNS with_IN C_NNP 2_CD C_NNP 12_CD cells_NNS led_VBN to_TO the_DT
        formation_NN of_IN hESMPC-derived_JJ myotubes_NNS ,_, as_IN visualized_JJ by_IN expression_NN of_IN human_JJ nuclear_JJ antigen_NN
        (_( Figure_NN 3_CD B_NNP )_) ,_, similar_JJ to_TO those_DT formed_VBN by_IN host_NN C_NNP 2_CD C_NNP 12_CD cells_NNS ._. After_IN 1_CD wk_NN of_IN coculture_NN ,_, myotubes_NNS
        composed_VBN of_IN human_JJ nuclei_NN accounted_VBD for_IN more_JJR than_IN 10_CD %_NN of_IN the_DT total_JJ number_NN of_IN human_JJ cells_NNS
        present_JJ ,_, and_CC each_DT human_JJ myotube_NN was_VBD composed_VBN of_IN up_IN to_TO ten_CD human_JJ nuclei_NN ._. Human_JJ cell_NN
        contribution_NN to_TO myotubes_NNS in_IN coculture_NN was_VBD confirmed_VBN by_IN expression_NN of_IN human_JJ muscle-specific_JJ
        transcripts_NNS such_JJ as_IN 
        MyoD_NNP ,_, myosin_NN heavy_JJ chain_NN IIa_NNP ,_, and_CC 
        myogenin_NN (_( data_NNS not_RB shown_VBN )_) ._. These_DT data_NNS demonstrate_VBP that_IN hESMPCs_NNS can_MD give_VB
        rise_NN to_TO mesenchymal_NN derivatives_NNS typically_RB obtained_VBN from_IN primary_JJ adult_NN MSCs_NNP ,_, as_RB well_RB as_IN to_TO
        cells_NNS expressing_VBG markers_NNS of_IN skeletal_NN muscle_NN ._.
        One_CD concern_NN for_IN the_DT clinical_JJ application_NN of_IN hESC-derived_JJ progeny_NN in_IN regenerative_JJ
        medicine_NN is_VBZ the_DT risk_NN of_IN teratoma_NN formation_NN due_JJ to_TO the_DT presence_NN of_IN residual_JJ undifferentiated_JJ
        ES_NNP cells_NNS among_IN the_DT differentiated_JJ progeny_NN ._. We_PRP did_VBD not_RB detect_VB markers_NNS of_IN undifferentiated_JJ
        hESCs_NNS ,_, such_JJ as_IN 
        Nanog_NNP [_NN 15_CD ]_NN or_CC 
        Oct-_NNP 4_CD [_NN 16_CD ]_NN ,_, in_IN any_DT of_IN the_DT hESMPCs_NNS by_IN RT-PCR_NNP (_( see_VB Figure_NN 2_CD D_NNP )_) and_CC
        immunocytochemistry_NN (_( data_NNS not_RB shown_VBN )_) ,_, suggesting_VBG the_DT lack_NN of_IN any_DT undifferentiated_JJ ES_NNP cells_NNS
        in_IN hESMPC_NN cultures_NNS ._. However_RB ,_, future_NN in_IN vivo_NN studies_NNS are_VBP required_VBN to_TO rule_VB out_RP the_DT potential_NN
        of_IN these_DT cells_NNS for_IN teratoma_NN formation_NN ._.
      
      
        Discussion_NNP
        Previous_JJ studies_NNS have_VBP demonstrated_VBN the_DT derivation_NN of_IN neural_NN cells_NNS [_NN 1_CD –_NN 3_CD ]_NN ,_, hematopoietic_JJ
        [_NN 17_CD ]_NN and_CC endothelial_NN lineages_NNS [_NN 18_CD ]_NN ,_, and_CC cardiomyocytes_NNS [_NN 19_CD ]_NN from_IN hESCs_NNS ._. This_DT study_NN presents_VBZ
        the_DT induction_NN of_IN paraxial_NN mesoderm_NN with_IN the_DT generation_NN of_IN multipotent_NN mesenchymal_NN
        precursors_NNS ._. We_PRP calculate_VBP that_IN under_IN these_DT conditions_NNS a_DT single_JJ undifferentiated_JJ hESC_NN yields_NNS
        an_DT average_NN of_IN one_CD CD_NNP 73_CD +_NN cell_NN at_IN day_NN 40_CD of_IN differentiation_NN ,_, suggesting_VBG a_DT balance_NN between_IN
        cell_NN proliferation_NN and_CC cell_NN selection_NN ._. There_EX were_VBD no_DT obvious_JJ differences_NNS in_IN marker_NN and_CC
        gene-expression_JJ profile_NN or_CC in_IN differentiation_NN behavior_NN among_IN the_DT five_CD hESMPC_NN lines_NNS
        generated_VBN ._. However_RB ,_, some_DT of_IN the_DT lines_NNS (_( e_SYM ._. g_SYM ._. ,_, hESMPC_NN 9_CD ._. 1_LS )_) exhibited_VBN a_DT tendency_NN of_IN spontaneous_JJ
        osteogenic_JJ differentiation_NN after_IN long-term_JJ propagation_NN ._. Directed_NNP differentiation_NN of_IN hESCs_NNS
        into_IN somatic_JJ stem-cell-like_JJ precursors_NNS represents_VBZ a_DT substantial_JJ advancement_NN in_IN harnessing_VBG
        the_DT developmental_NN potential_NN of_IN hESCs_NNS ._. The_DT high_JJ purity_NN ,_, unlimited_JJ availability_NN ,_, and_CC
        multipotentiality_NN of_IN hESMPCs_NNS will_MD provide_VB the_DT basis_NN for_IN future_JJ therapeutic_JJ efforts_NNS using_VBG
        these_DT cells_NNS in_IN preclinical_JJ animal_NN models_NNS of_IN disease_NN ._. Such_JJ in_IN vivo_NN studies_NNS will_MD also_RB be_VB
        required_VBN to_TO properly_RB assess_VB the_DT safety_NN profile_NN of_IN these_DT cells_NNS ._. Furthermore_RB ,_, our_PRP$ system_NN also_RB
        offers_VBZ a_DT novel_NN platform_NN to_TO study_VB basic_JJ mechanisms_NNS of_IN mesodermal_NN induction_NN and_CC
        differentiation_NN during_IN early_JJ human_JJ development_NN ._.
      
      
        Supporting_VBG Information_NNP
        
          Accession_NNP Numbers_NNPS
          The_DT Gene_NNP Expression_NNP Omnibus_NN (_( GEO_NNP )_) (_( http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN geo_NN )_) accession_NN number_NN
          for_IN all_DT raw_JJ microarray_NN data_NNS used_VBN in_IN this_DT study_NN is_VBZ GSE_NNP 2248_CD ._.
          The_DT Unigene_NNP (_( http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN entrez_NN /_NN query_NN ._. fcgi_NN ?_. db_NN =_SYM unigene_NN )_) accession_NN
          numbers_NNS for_IN the_DT gene_NN products_NNS discussed_VBN in_IN this_DT paper_NN are_VBP aggrecan_NN (_( Hs_NNP ._. 2159_CD
          [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 2159_CD ;_: bone_NN sialoprotein_NN
          (_( Hs_NNP ._. 518726_CD [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 518726_CD ;_:
          bone-specific_JJ alkaline_NN phosphatase_NN (_( Hs_NNP ._. 75431_CD
          [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 75431_CD ;_: collagen_NN II_NNP
          (_( Hs_NNP ._. 408182_CD [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 408182_CD ;_: forkhead_NN
          box_NN D_NNP 1_CD (_( Hs_NNP ._. 519385_CD [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 519385_CD ;_:
          hepatocyte_NN growth_NN factor_NN (_( Hs_NNP ._. 396530_CD
          [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 396530_CD ;_: mesenchymal_NN stem_NN
          cell_NN protein_NN (_( DSC_NNP 54_CD ,_, Hs_NNP ._. 157461_CD
          [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 157461_CD ;_: MyoD_NNP (_( Hs_NNP ._. 520119_CD
          [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 520119_CD ;_: myogenin_NN (_( Hs_NNP ._. 2830_CD
          [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 2830_CD ;_: myosin_NN heavy_JJ chain_NN
          IIa_NNP (_( Hs_NNP ._. 513941_CD [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 513941_CD ;_:
          Nanog_NNP (_( Hs_NNP ._. 329296_CD [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 329296_CD ]_NN )_)
          [_NN 15_CD ]_NN ;_: neuropilin_NN 1_CD (_( Hs_NNP ._. 131704_CD
          [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 131704_CD ;_: notch_NN homolog_NN 2_CD
          (_( Hs_NNP ._. 549056_CD [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 549056_CD ;_: Oct-_NNP 4_CD
          (_( Hs_NNP ._. 504658_CD [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 504658_CD ;_: and_CC
          PPARγ_NNP (_( Hs_NNP ._. 162646_CD
          [_NN http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN clust_NN ._. cgi_NN ?_. ORG_NNP =_SYM Hs_NNP &_CC CID_NNP =_SYM 162646_CD ]_NN )_) ._.
        
      
    
  
